QFA
IBB icon

Quattro Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Quattro Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-136
Closed -$264K – 84
2023
Q4 		$264K Sell
136
-1,804
-93% -$220K 0.09% 74
2023
Q3 		$237K Hold
1,940
– – 0.1% 73
2023
Q2 		$246K Hold
1,940
– – 0.1% 72
2023
Q1 		$251K Sell
1,940
-107
-5% -$14K 0.1% 70
2022
Q4 		$269K Sell
2,047
-157
-7% -$20.3K 0.11% 65
2022
Q3 		$258K Sell
2,204
-954
-30% -$118K 0.1% 71
2022
Q2 		$371K Buy
3,158
+339
+12% +$40.2K 0.13% 66
2022
Q1 		$367K Sell
2,819
-15,141
-84% -$1.97M 0.12% 63
2021
Q4 		$2.74M Buy
17,960
+6,704
+60% +$1.04M 0.97% 27
2021
Q3 		$1.78M Sell
11,256
-15,749
-58% -$2.65M 0.47% 43
2021
Q2 		$4.29M Sell
27,005
-2,271
-8% -$350K 1.15% 25
2021
Q1 		$4.45M Buy
29,276
+3,281
+13% +$521K 1.01% 26
2020
Q4 		$4.21M Sell
25,995
-422
-2% -$60.3K 1.11% 25
2020
Q3 		$3.66M Sell
26,417
-1,343
-5% -$182K 0.88% 27
2020
Q2 		$3.86M Sell
27,760
-11,363
-29% -$1.45M 1.01% 21
2020
Q1 		$2.66M Buy
39,123
+38,111
+3,766% +$4.39M 0.97% 22
2019
Q4 		$123K Sell
1,012
-1,035
-51% -$115K 0.04% 54
2019
Q3 		$201K Hold
2,047
– – 0.06% 57
2019
Q2 		$218K Buy
+2,047
New +$218K 0.07% 51
2019
Q1 		– Sell
-4,238
Closed -$465K – 38
2018
Q4 		$465K Sell
4,238
-7,472
-64% -$793K 0.16% 43
2018
Q3 		$1.35M Buy
11,710
+2,399
+26% +$282K 0.49% 38
2018
Q2 		$1.04M Sell
9,311
-1,778
-16% -$190K 0.52% 25
2018
Q1 		$1.16M Buy
11,089
+7,393
+200% +$820K 0.46% 28
2017
Q4 		$405K Sell
3,696
-270
-7% -$28.9K 0.11% 48
2017
Q3 		$448K Buy
3,966
+375
+10% +$40.1K 0.13% 63
2017
Q2 		$371K Sell
3,591
-273
-7% -$26.9K 0.15% 49
2017
Q1 		$378K Buy
+3,864
New +$370K 0.19% 46

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Quattro Financial Advisors's IBB Position: Q1 2024 in Review

Quattro Financial Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2024, closing a stake of 136 shares — an estimated $264K sold.

Quattro Financial Advisors first reported a position in IBB in Q1 2017 and held it in 27 quarters. The position peaked at $4.45M in Q1 2021. 899 funds tracked by Wall St. Rank hold IBB as of Q1 2024.

  • Quattro Financial Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2024 after selling out during the quarter.
  • Quattro Financial Advisors sold 136 iShares Biotechnology ETF shares in Q1 2024, an estimated $264K.
  • Quattro Financial Advisors first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 27 quarters.
  • Quattro Financial Advisors's iShares Biotechnology ETF position peaked at $4.45M in Q1 2021.
  • 899 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.

Based on Quattro Financial Advisors's 13F filing for Q1 2024, filed 18 Apr 2024.